Induztr
Résumé technique Visionneuse de documents Modèles associés

Analysis of Sulfonamide Drugs

Sommaire

  1. Overview p. 2
    Introduces sulfonamide drugs and analytical context
  2. p. 3
    Presents and discusses analysis results
  3. Spec p. 4
    Covers method sensitivity and related performance data
  4. p. 5
    Summarizes findings and method suitability
  5. p. 2 table, 23 rows
  6. p. 4 table, 19 rows
  7. p. 5 table, 19 rows

Table 2. Target analytes MRM conditions.

No.AnalytePrecursor Ion (m/z)Fragmentor (V)Quant Product Ion (m/z)CE (V)Qual Product Ion (m/z)CE (V)
1Sulfacetamide215.265156710820
2Sulfadiazine251.3100156169232
3Sulfathiazole256100156.11465.256
4Sulfapyridine250.311091.93215616
5Sulfamerazine265.3110923265.258
6Trimethoprim291.3120230.12626128
7Sulfamethoxypyridazine281.31001561692.232
8Sulfamoxole271.39092.12865.156
9Sulfadimidine279.310065.26492.132
10Sulfameter281.31101561692.234
11Sulfachloropyridazine285100156149236
12Sulfamethoxazole254.310065.25415616
13Sulfamonomethoxine281.3701561892.234
14Sulfisoxazole268.3100155.91292.130
15Sulfadoxine311.4130156189234
16Sulfabenzamide277.2801561210828
17Sulfaphenazole315.413065789243
18Sulfadimethoxine311.4130156229238
19Sulfaquinoxaline301.4110156.11692.136
IS 113C6-Sulfadiazine25611016217––
IS 213C3-Trimethoprim29412023038––
IS 313C6-Sulfadimethoxine31713016221––
IS 413C6-Sulfamoxole2779016228––

Table 3. The 19 targeted SA drugs quantitation results.

TargetRetention Time (min)Calibration Curve Linearity (R2)LOD (ng/L)LOQ (ng/L)
Sulfacetamide2.840.9990.291.16
Sulfadiazine3.990.9990.773.08
Sulfathiazole4.690.9991.094.36
Sulfapyridine5.010.9990.833.32
Sulfamerazine5.470.9991.355.4
Trimethoprim6.280.9991.234.92
Sulfamethoxypyridazine6.440.9991.014.04
Sulfamoxole6.690.9990.281.12
Sulfadimidine6.960.9991.244.96
Sulfameter7.240.9991.355.4
Sulfachloropyridazine7.480.9990.863.44
Sulfamethoxazole7.710.9990.983.92
Sulfamonomethoxine8.080.9990.311.24
Sulfisoxazole8.560.9961.516.04
Sulfadoxine8.620.9991.244.96
Sulfabenzamide9.110.9991.887.52
Sulfaphenazole10.210.9990.833.32
Sulfadimethoxine11.190.9990.933.72
Sulfaquinoxaline11.880.9991.265.04

Table 4. Spiking recovery and precision of targets in ground surface water at a level of 100 ng/L (n = 3).

No.CompoundAverage Recovery (%)RSD (%)
1Sulfacetamide95.03.6
2Sulfadiazine94.42.1
3Sulfathiazole87.40.2
4Sulfapyridine85.33.4
5Sulfamerazine91.81.2
6Trimethoprim1020.9
7Sulfamethoxypyridazine89.81.2
8Sulfamoxole88.52.0
9Sulfadimidine84.05.4
10Sulfameter94.63.11
11Sulfachloropyridazine88.64.9
12Sulfamethoxazole99.52.6
13Sulfamonomethoxine94.35.3
14Sulfisoxazole87.54.5
15Sulfadoxine77.96.8
16Sulfabenzamide86.82.4
17Sulfaphenazole78.47.0
18Sulfadimethoxine78.68.2
19Sulfaquinoxaline73.48.8

Engineering Facts

14 facts · every claim linked to a page
Selection

The HLB sorbent retains a broad range of compounds from polar to nonpolar and acidic to basic, so it is suitable for multi-class environmental screening.

Confirms method scope and sorbent suitability when selecting an SPE chemistry for mixed-analyte water methods.

Source
“This SPE sorbent provides good retention for a broad range of compounds from polar, to intermediate polar, to nonpolar compounds, and from acidic, to neutral, to basic compounds.”
Selection

The specific cartridge part number and format used are 6 mL, 500 mg Bond Elut HLB (p/n 5610-2147), which must be ordered to reproduce the method.

Ensures correct consumable selection and avoids method deviation from a different bed mass or format.

Source
“Bond Elut HLB cartridges, 6 mL, 500 mg (part number 5610-2147)”
Installation

The SPE workflow requires a vacuum manifold with a collection rack for 10 × 75 mm test tubes (p/n 12234003).

Defines the manifold and collection hardware needed to set up the extraction bench correctly.

Source
“Agilent Vac Elut SPS 24 manifold with collection rack for 10 × 75 mm test tubes (part number 12234003)”
Operation

Adding NaEDTA raises sample pH to about 9 and degrades retention of sulfacetamide and sulfadiazine, so pH must be controlled.

Warns operators that EDTA addition alone is insufficient and pH adjustment is mandatory for reliable recovery.

Source
“the addition of NaEDTA to the water sample turned the water slightly basic, with a pH ~9, leading to unacceptable results and compromising sulfacetamide and sulfadiazine retention on the HLB sorbent.”
Operation

The sample must be adjusted to pH 4 to 7 with diluted HCl before loading to achieve best retention of the sulfonamides.

Specifies the critical pH window that governs analyte retention on the HLB cartridge.

Source
“Use diluted HCl to adjust the water to pH 4 to 7, then add 20 ng of IS 4.”
Operation

Cartridges are preconditioned with 6 mL MeOH and equilibrated with 6 mL water before sample loading.

Defines the conditioning sequence required to activate the sorbent and avoid poor or variable recovery.

Source
“Precondition the HLB cartridges with 6 mL of MeOH, and equilibrate with 6 mL of water.”
Operation

Sample loading should be performed at approximately 5 mL/min under vacuum to control residence time on the sorbent.

Gives the flow rate needed to keep loading reproducible and prevent breakthrough.

Source
“Transfer the prepared water sample gradually into the SPE cartridge, and apply vacuum for elution at ~5 mL/min.”
Operation

Elution uses 8 mL of MeOH (4 mL × 2) because 3 mL was insufficient for sulfamoxole and sulfabenzamide and 6 mL was marginal.

Specifies the elution volume and sequence needed to fully recover all 19 targets, including the more retentive ones.

Source
“Elute the HLB cartridges with MeOH, 4 mL × 2, and collect the eluent.”
Operation

The cartridge must be dried completely under high vacuum after the water wash before elution.

Residual water on the sorbent can dilute the eluate and reduce recovery; complete drying is a required step.

Source
“Wash the cartridge with 6 mL of water, and apply high vacuum at the end to dry the cartridge completely.”
Operation

The eluate is dried under nitrogen at 40 °C and reconstituted in 1 mL of 1:1 MeOH:water containing ISTDs 1–3.

Defines the concentration step and final solvent composition that affect injection and quantitation.

Source
“Dry the eluent with N2 flow at 40 °C, then reconstitute with 1 mL of 1:1 MeOH:water spiked with IS 1 to 3.”
Operation

The reconstituted sample must be filtered through a 0.2 µm nylon filter before LC/MS/MS injection.

Prevents particulates from reaching the column and injector, protecting the LC/MS system.

Source
“Filter the reconstituted sample with a 0.2 µm nylon filter. Samples are now ready for LC/MS/MS analysis.”
Performance

The method achieves LODs of 0.3 to 1.9 ng/L and LOQs of 1.2 to 7.6 ng/L, confirming suitability for trace-level water analysis.

Provides the sensitivity baseline engineers need to judge whether the method meets a given regulatory limit.

Source
“The LODs for all 19 SA drugs were within 0.3 to 1.9 ng/L, and limits of quantitation (LOQ) ranged between 1.2 to 7.6 ng/L.”
Performance

Recovery in spiked blank water is 74.3 to 118% for most targets, with sulfisoxazole below 65% at 4 and 10 ng/L.

Flags a known low-recovery analyte at trace levels so expectations and QC limits can be set realistically.

Source
“the recovery of 74.3 to 118% was achieved for most targets at four spiking levels, except the slight low recoveries (< 65%) of sulfisoxazole at the levels of 4 and 10 ng/L.”
Performance

In real ground surface water spiked at 100 ng/L, recovery is 73.4 to 102% with RSD 0.2 to 8.8%, confirming matrix applicability.

Demonstrates the method works in a real matrix, supporting its adoption for environmental monitoring.

Source
“The recovery of all of the targets ranged from 73.4 to 102%, with RSDs between 0.2 and 8.8%.”